Senior insider sale
EVP and CFO at MADRIGAL PHARMACEUTICALS, INC. — senior position signals high conviction
$2.42M
4.17K shares
What this filing means
DIER MARDI plans to sell 4.17K shares of MADRIGAL PHARMACEUTICALS, INC. valued at approximately $2.42M. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 12/2/2025ACC: 0001950047-25-009623
Officer· EVP and CFO
Since Mar 2026
4.17K
Shares to sell
$2.42M
Approx. market value
4.17K
Acquired (3 months)
1
Planned
Securities Acquired — Last 3 Months1
Exercise of Stock Options
Cash
12/2/2025
4.17KTotal acquired4.17K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
12/2/2025 | Exercise of Stock Options Cash | 4.17K | — |
| Total | 4.17K | ||
Planned & Completed Dispositions1
NASDAQPlanned
Units to sell
4.17K
Market value
$2.42M
12/2/2025
Total
Units
4.17K
Value
$2.42M
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
12/2/2025 | 4.17K | $2.42M | NASDAQ | Planned |
| Total | 4.17K | $2.42M | ||